Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1301.752
  • +10.397+0.81%
Close Dec 24 13:00 ET
1304.839High1282.311Low
Constituent Stocks: 10Top Rising: SGMO+4.60%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
SGMOSangamo Therapeutics
2.5000.110+4.60%2.52M6.07M2.3202.3902.5002.290521.62M510.09M208.65M204.04M-11.35%+28.21%+28.87%+188.65%+675.19%+365.55%+360.15%--1.24%LossLoss8.78%Biotechnology
BLUEbluebird bio
7.7900.130+1.70%260.86K2.06M7.6307.6608.2407.57075.74M75.38M9.72M9.68M-13.15%-6.80%+7.69%-25.02%-57.81%-72.18%-71.78%--2.70%LossLoss8.74%Biotechnology
CRSPCRISPR Therapeutics
40.9400.460+1.14%759.87K30.80M40.48040.48041.01539.8003.49B3.44B85.35M83.95M-8.27%-15.90%-18.77%-12.86%-22.90%-36.98%-34.60%--0.91%LossLoss3.00%Biotechnology
AAgilent Technologies
136.1001.500+1.11%370.22K50.23M134.600134.600136.100134.15038.87B38.72B285.60M284.52M-0.26%-4.11%+1.20%-8.19%+7.87%-2.00%-1.61%0.69%0.13%30.7230.721.45%Diagnostics & Research
VRTXVertex Pharmaceuticals
408.1802.910+0.72%1.47M598.40M401.530405.270410.680401.270105.12B104.82B257.53M256.79M-13.01%-13.01%-11.59%-12.23%-13.99%+0.03%+0.32%--0.57%Loss29.392.32%Biotechnology
BEAMBeam Therapeutics
28.8100.110+0.38%263.59K7.57M28.77028.70029.12028.0002.39B1.98B82.81M68.58M+0.80%-4.60%+8.11%+17.59%+24.83%-0.93%+5.84%--0.38%LossLoss3.90%Biotechnology
APLSApellis Pharmaceuticals
33.3200.110+0.33%437.76K14.49M33.21033.21033.39032.5004.14B2.81B124.39M84.36M-3.50%-3.81%+4.42%+15.53%-8.06%-47.06%-44.34%--0.52%LossLoss2.68%Biotechnology
NTLAIntellia Therapeutics
12.050-0.050-0.41%859.60K10.37M12.12012.10012.21011.8301.23B1.21B101.85M100.57M-8.23%-18.14%-18.53%-41.36%-47.06%-62.04%-60.48%--0.86%LossLoss3.14%Biotechnology
EDITEditas Medicine
1.210-0.040-3.20%1.58M1.93M1.2401.2501.2601.20099.88M93.56M82.55M77.32M-20.39%-42.38%-49.16%-64.52%-73.64%-88.34%-88.06%--2.04%LossLoss4.80%Biotechnology
CRBUCaribou Biosciences
1.690-0.100-5.59%1.10M1.85M1.7901.7901.8051.650153.03M137.87M90.55M81.58M-12.89%-16.75%-16.34%-13.78%+5.63%-71.40%-70.51%--1.35%LossLoss8.66%Biotechnology

Comments

Read more